ClinicalRM becomes ICON GPHS to rapidly respond to global health crises, says CRO

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/Hankimage9)
(Image: Getty/Hankimage9)
ClinicalRM – which ICON acquired in 2016 – has become ICON Government and Public Health Solutions (GPHS), providing full-service clinical trial execution and functional services to government, NGOs, and commercial customers.

The contract research organization (CRO) Icon plc completed its acquisition of Clinical Research Management, Inc. (ClinicalRM) in September 2016.

Today, as ICON GPHS, the company has more than 380 personnel globally to provide “boots-on-the-ground and rapid response efforts to global health crises,” ​explained Dr. James F. Cummings, president of ICON GPHS

“The launch of ICON GPHS has been a process since ICON first acquired ClinicalRM some 18 months ago,”​ he told us.

ICON GPHS provides full-service clinical development and staffing services to support US federal research, the public health sector including non-government organizations (NGOs), academic institutions, and others.

“This is more than a rebranding effort, it is strengthening the high-quality work and enhancing the value that ICON GPHS already brings to the global health space by leveraging the broader clinical research capabilities for which ICON is world renowned,”​ Cummings added.

Related news

Show more

Related products

show more


Sterile Injectables Contract Manufacturing

Baxter BioPharma Solutions | 02-Apr-2018 | Product Brochure

Baxter BioPharma Solutions' award-winning facility in Bloomington, Indiana, USA, is a leader in sterile contract manufacturing of injectable products.


Lyophilization Scale-Up and Tech Transfer

Baxter BioPharma Solutions | 12-Mar-2018 | Technical / White Paper

There are few challenges when increasing the scale of production for a solution formulation, but the challenges drastically increase when the formulation...

Leveraging Best Practices in Primary Packaging

Leveraging Best Practices in Primary Packaging

Catalent Pharma Solutions | 05-Mar-2018 | Technical / White Paper

When planning a clinical trial, overlooking the importance of primary packaging can be a mistake. From stability concerns to labeling to patient compliance...

VDS groß

Meet the challenges of complex injectables

Vetter Pharma International GmbH | 07-Nov-2017 | Technical / White Paper

In the time it takes from the exciting discovery phase to the rigorous demands of a commercial launch, unexpected scientific and technical challenges can...

Related suppliers